S
Serge Gauthier
Researcher at McGill University
Publications - 715
Citations - 61038
Serge Gauthier is an academic researcher from McGill University. The author has contributed to research in topics: Dementia & Disease. The author has an hindex of 93, co-authored 637 publications receiving 52775 citations. Previous affiliations of Serge Gauthier include Hamamatsu University School of Medicine & La Salle University.
Papers
More filters
Book
Vascular Cognitive Impairment in Clinical Practice
TL;DR: The use of the term “vascular cognitive impairment” (VCI) has a fairly recent history and was conceptualized in two widely promulgated sets of consensus-based criteria.
Journal ArticleDOI
The ACTION study: methodology of a trial to evaluate safety and efficacy of a higher dose rivastigmine transdermal patch in severe Alzheimer's disease
TL;DR: A novel trial in the development of rivastigmine, as it uses a design that does not include a placebo arm, is recruiting patients with severe AD, and includes an ADL measure as a co-primary efficacy variable.
Journal ArticleDOI
In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals
Eduardo R. Zimmer,Eduardo R. Zimmer,Eduardo R. Zimmer,Antoine Leuzy,Antoine Leuzy,Venkat Bhat,Serge Gauthier,Pedro Rosa-Neto,Pedro Rosa-Neto +8 more
TL;DR: Several novel positron emission tomography radiopharmaceuticals targeting tau tangles have been developed, allowing for non-invasive in vivo quantification of tau pathology and holding the promise of advancing the development of theoretical models and advancing the understanding of the natural history of AD and non-AD tauopathies.
Journal ArticleDOI
International price comparisons of Alzheimer's drugs: a way to close the affordability gap.
Guk-Hee Suh,Anders Wimo,Serge Gauthier,Daniel William O'Connor,Manabu Ikeda,Akira Homma,Jacqueline Dominguez,Bong-Min Yang +7 more
TL;DR: Alzheimer's drugs, albeit available, are often unaffordable for those who need them most, and in terms of PPP, Alzheimer's drugs in other low- and middle- income countries are much more expensive than in high-income countries.
Journal ArticleDOI
Severe Impairment Battery Language scale: A language-assessment tool for Alzheimer's disease patients
Steven H. Ferris,Ralf Ihl,Philippe Robert,Bengt Winblad,Gudrun Gatz,Frank Tennigkeit,Serge Gauthier +6 more
TL;DR: A new scale, based on the language subscale of the Severe Impairment Battery, is created as a sensitive and reliable measurement of treatment effects on language performance in Alzheimer's disease patients.